Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

NALP4f Activators

The speculative class of NALP4f Activators comprises an array of small molecule compounds that may indirectly influence the regulatory mechanisms and cellular activities associated with the NALP4f protein. These activators do not directly bind or modulate NALP4f; rather, they exert their potential effects by interfacing with various biochemical pathways that could converge on the functional state of NALP4f. The compounds selected target assorted biochemical processes, such as cyclic nucleotide synthesis, actin cytoskeleton integrity, intracellular calcium levels, and kinase signaling cascades. For instance, compounds like Forskolin, which enhance cAMP levels, may indirectly affect NALP4f through cAMP-dependent protein kinase (PKA) pathways that can phosphorylate proteins interacting with NALP4f. Similarly, agents that modulate the actin cytoskeleton, such as Phalloidin, Jasplakinolide, and Latrunculin A, could potentially alter the activity of NALP4f by impacting actin dynamics and related signaling. These compounds affect the polymerization and stability of actin filaments, integral components of cell structure and signaling mechanisms. Changes in actin organization can trigger cascades of intracellular events, possibly reaching and influencing NALP4f functionality.

Furthermore, chemicals like Y-27632 and ML-7, which inhibit kinases associated with the actin-myosin contractile machinery, may create a cellular context conducive to NALP4f activation by altering cellular contractility and motility. Compounds such as Thapsigargin and Ionomycin elevate intracellular calcium, a second messenger involved in myriad signaling pathways, some of which NALP4f might participate in. The modulation of calcium signaling could also potentially result in NALP4f activation, considering the widespread influence of calcium on cellular processes. The indirect activation of NALP4f by this diverse set of compounds relies on the premise that NALP4f is integrated into cellular signaling networks responsive to altered levels of second messengers, cytoskeletal dynamics, and kinase activity. Each compound in this class has been chosen for its ability to perturb specific cellular processes, creating a ripple effect that may ultimately touch upon and modulate the activity of NALP4f. It is through these intricate and multifaceted mechanisms that the indirect activation of NALP4f could be achieved.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which is involved in various signaling cascades. PKC could modulate the activity of proteins associated with NALP4f, resulting in its indirect activation.

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$96.00
$264.00
2
(2)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting calcium-dependent signaling pathways that engage NALP4f.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is another calcium ionophore that alters calcium homeostasis, which could influence signaling pathways that modulate the activity of NALP4f.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, affecting the PI3K/Akt pathway. This can lead to alterations in cellular processes that may indirectly activate NALP4f.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor which might impact stress response pathways and cellular processes, potentially influencing NALP4f activation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), modifying signaling pathways that can affect various cellular events, possibly including those related to NALP4f activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 acts as an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. By affecting this pathway, PD98059 may indirectly influence the activity of NALP4f.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is a central regulator of cell growth and metabolism. This inhibition could impact processes that are potentially connected to NALP4f activation.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Gö 6983 is a broad-spectrum PKC inhibitor that can modify multiple signaling pathways, potentially influencing cellular processes where NALP4f is involved.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). By affecting CaMKII activity, KN-93 may indirectly modulate pathways associated with NALP4f.